Isis Pharma (ISIS) Tops Q3 EPS by 1c

Isis Pharma (NASDAQ: ISIS) reported Q3 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $49.1 million versus the consensus estimate of $52.93 million.

For earnings history and earnings-related data on Isis Pharma (ISIS) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Logistic Properties of the Americas (LPA) Reports Q2 results
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance